Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312429 · ClinicalTrials.gov registry record · Phase 1
Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT00312429 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 34 participants.
The verdict
NCT00312429, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Umbilical cord blood is an important source of stem cells and can be used to treat blood and immune system disorders and certain types of cancer. Stem cell transplants of umbilical cord blood have been shown to be effective in treating illness in children, but more research is needed to confirm the benefit of this procedure in adults. The purpose of this study is to examine the immune system response to cord blood stem cell transplantation in adults with advanced blood disorders or cancer.
Interventions
- PROCEDURE Stem Cell Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2002-01 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00312429
The ClinicalTrials.gov registry entry for NCT00312429 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stem Cell Transplantation is the first listed.
NCT00312429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00312429 about?
NCT00312429 is a clinical study titled "Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer". Umbilical cord blood is an important source of stem cells and can be used to treat blood and immune system disorders and certain types of cancer. Stem cell transplants of umbilical cord blood have been shown to be effective in treating illness in children, but more research is needed to confirm the ...
What is the current status of trial NCT00312429?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2002-01. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00312429?
The interventions under investigation include: Stem Cell Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00312429?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.